Maze Therapeutics Inc (MAZE)

EBITDA Growth

-31.41%

Quarterly · Period ending:

MAZE logo

MAZE EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-31.41%
MAZE Quarterly EBITDA YoY % (-2.11% → -31.41%)
High-resolution chart · PNG

MAZE ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Maze Therapeutics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-31.4108%
28.6711%
-16.8788%
-21.7506%
-123.3203%
-1.769%
-13.8588%
-2.1059%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.